Inferior vena cava syndrome as the initial manifestation of metastatic prostate cancer: a rare case successfully treated with endovascular stenting
DOI:
https://doi.org/10.2340/sju.v60.43708Keywords:
Inferior vena cava syndrome, prostate cancer, retroperitoneal metastasis, case reportDownloads
References
Lawrensia S, Khan YS. Inferior vena cava syndrome. Treasure Island, FL: StatPearls Publishing; 2024 [updated 2023 May 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560885/ [cited November 7th 2024]
Chaudhary RK, Nepal P, Kumar S, et al. Imaging of inferior vena cava normal variants, anomalies and pathologies, Part 2: acquired. SA J Radiol. 2023;27(1):2694. https://doi.org/10.4102/sajr.v27i1.2694 DOI: https://doi.org/10.4102/sajr.v27i1.2694
Friedman T, Quencer KB, Kishore SA, et al. Malignant venous obstruction: superior vena cava syndrome and beyond. Semin Intervent Radiol. 2017;34(4):398–408. https://doi.org/10.1055/s-0037-1608863 DOI: https://doi.org/10.1055/s-0037-1608863
Morita S, Sugawara S, Suda T, et al. Stent placement for malignant inferior vena cava syndrome in a patient with recurrent colon cancer. Intern Med. 2020;59(22):2885–2890. https://doi.org/10.2169/internalmedicine.5033-20 DOI: https://doi.org/10.2169/internalmedicine.5033-20
Kuetting D, Thomas D, Wilhelm K, et al. Endovascular management of malignant inferior vena cava syndromes. Cardiovasc Intervent Radiol. 2017;40(12):1873–1881. https://doi.org/10.1007/s00270-017-1740-z DOI: https://doi.org/10.1007/s00270-017-1740-z
Epelboym Y, Stecker MS, Fan CM, et al. Treatment of malignant inferior vena cava obstruction with Gianturco-Rosch-Z stents: a single center 13-year experience. Clin Imaging. 2020;59(2):95–99. https://doi.org/10.1016/j.clinimag.2019.09.015 DOI: https://doi.org/10.1016/j.clinimag.2019.09.015
Augustin AM, Lucius LJ, Thurner A, et al. Malignant obstruction of the inferior vena cava: clinical experience with the self-expanding Sinus-XL stent system. Abdom Radiol (NY). 2022;47(10):3604–3614. https://doi.org/10.1007/s00261-022-03587-1 DOI: https://doi.org/10.1007/s00261-022-03587-1
Stranne J. 2023/2024 update of the national prostate cancer guidelines in Sweden. Scand J Urol. 2024;59:210–211. https://doi.org/10.2340/sju.v59.42656 DOI: https://doi.org/10.2340/sju.v59.42656
Wei W, Gong C, Wei R, et al. Metastatic prostate cancer presenting as generalized lymphadenopathy and progressing with inferior vena cava syndrome: a case report and literature review. Oncol Lett. 2024;28(6):557. https://doi.org/10.3892/ol.2024.14690 DOI: https://doi.org/10.3892/ol.2024.14690
Makusha LP, Kulon M, Pucar D, et al. Inferior vena cava syndrome on skeletal scintigraphy secondary to metastatic prostate cancer. World J Nucl Med. 2020;19(3):324–326. https://doi.org/10.4103/wjnm.WJNM_53_19 DOI: https://doi.org/10.4103/wjnm.WJNM_53_19
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dimitra Akrivou, Andreas Forsvall, Angelos Katevatis, Tobias Kühme, Anna Eliasson, Magnus Wagenius
This work is licensed under a Creative Commons Attribution 4.0 International License.
As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
